Medication Safety

Managing the risks associated with patients prescribed clozapine

28 June 2024Healthcare professionals in non-specialist services managing patients prescribed clozapine should implement safe practice principles to prevent potential harms.

Clinical considerations for patients prescribed clozapine

28 June 2024Healthcare professionals in all settings who interact with patients prescribed clozapine should be aware of clinical considerations related to its use.

Managing complexities of medication use across care boundaries

26 June 2024Exploring the risks for patients on complex or specialist medicines moving across care boundaries with a focus on strategies to reduce harms

Medication Safety Update

21 June 2024A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.

Purchasing for safety

19 June 2024Using principles of purchasing for safety when making purchasing decisions supports the safe clinical use of medicines and can minimise inadvertent harm

Investigating suspected tampering with medicines

11 June 2024A systematic approach should be taken to responding to reports of possible malicious tampering, securing the evidence, and seeking specialist advice and support

Managing risks of betamethasone soluble tablets used as mouthwash

13 May 2024Serious side effects can be caused if betamethasone soluble tablets used as mouthwash are swallowed. Providing clear patient directions can help prevent harm.

Ensuring time critical use of rasburicase

6 March 2024Timely use of rasburicase for treatment of tumour lysis syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy.

MSATS – Safe use of valproate

28 February 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of valproate; inspiring partnership across the system

Managing the risks of using liquid oral phenobarbital

2 November 2023Minimising the risk of confusion between phenobarbital liquid formulations and awareness of alcohol content may prevent harms.